Skip to main content

Nonfluent Aphasia, Progressive clinical trials at UCSF
1 research study open to eligible people

  • BIIB092 in Primary Tauopathies: CBS, nfvPPA, sMAPT, and TES

    open to eligible people ages 35-80

    A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel Cohort Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of Intravenously Infused BIIB092 in Patients with Four Different Primary Tauopathy Syndromes

    San Francisco, California

Last updated: